Pfizer Inc's (PFE) Outlook - CSIMarket
CSIMarket
 
Pfizer Inc  (NYSE: PFE)
 



  Pfizer Inc Outlook

On January 30 2024 the Pfizer Inc provided following guidance

Pfizer Inc. (NYSE: PFE) released its financial results for the fourth quarter and full year of 2023, also reconfirming its financial guidance for the full year of 2024. These estimates were initially provided on December 13, 2023.

The earnings presentation for the fourth quarter of 2023, along with prepared remarks from Pfizer's management, can be accessed on the company's website, www.pfizer.com. Additionally, the company has provided an update on its research and development (RandD) pipeline for the quarter.

Dr. Albert Bourla, Chairman and Chief Executive Officer, expressed his optimism about the strong performance of the company.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.